CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Understand when to rebalance for tax efficiency in retirement. This guide covers timing signals and simple checks to keep your portfolio compliant and efficient.
17,138 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A week of record heat pushed France's death toll higher, with official data showing around 1,000 additional deaths an...
Real estate firms lean on AI-powered ads and social media to attract buyers and sellers as 2026 data shows shifting o...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
Enphase Energy and SolarEdge surged roughly 8% in morning trading as investors chase AI data-center power plays, exte...
AI-generated listing videos are reshaping real estate marketing, but new disclosures aim to curb misrepresentation. T...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...
Massive passive flows into the Russell 2000 through IWM are lifting small caps, even as investors await the next Fed ...
Corning shared a 13% single-session drop after a meteoric AI fiber rally. Analysts say the pullback could be a health...
Meta faced a pivotal near-miss in 2026 as it stepped back from a Kalshi deal. The decision highlights how regulatory ...
Tokenized stocks emerge altcoin as a lifeline for investors seeking real-world asset exposure, even as traditional al...
As AI workloads expand, data center power stocks are seeing a fresh wave of orders and upgraded guidance. This report...